CYP21A2 Antibodies

Santa Cruz Biotechnology features a diverse variety of CYP21A2 monoclonal antibodies for research in steroidogenesis and adrenal function. CYP21A2 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP21A2, or cytochrome P450 21A2, plays a crucial role in the biosynthesis of steroid hormones, specifically in the conversion of progesterone to 11-deoxycorticosterone and 17-hydroxyprogesterone to 11-deoxycortisol. The enzyme is essential for proper adrenal gland function and is implicated in disorders such as congenital adrenal hyperplasia, which can lead to significant hormonal imbalances. Understanding CYP21A2 function is vital for advancing research in endocrinology and developing therapeutic strategies for related conditions. Research utilizing CYP21A2 monoclonal antibodies continues to reveal new insights into steroid hormone synthesis pathways. Investigating CYP21A2 expression patterns helps researchers better understand hormone-related disorders and potential treatments. Scientists exploring adrenal function rely on CYP21A2 monoclonal antibodies to map cellular mechanisms and pathways. Santa Cruz Biotechnology monoclonal antibodies for CYP21A2 support researchers worldwide in their mission to advance understanding of steroid hormone regulation and related diseases.